Cardiovascular risk factor management in patients with diabetes: Does management differ with disease duration?

Cardiovascular risk factor management in patients with diabetes: Does management differ with disease duration?

Our objective was to examine risk factor modification targets and treatment in relation to duration of diabetes. The Diabetes Mellitus Status in Canada (DM-SCAN) study collected data on 5109 patients with type 2 diabetes mellitus (T2DM) in 2012 in primary care. We compared the prevalence of vascular...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of diabetes and its complications 2021-10, Vol.35 (10), p.107997-107997, Article 107997
Hauptverfasser: Lo, Samantha, Leiter, Lawrence A., Langer, Anatoly, Tan, Mary, Goldin, Lianne, Harris, Stewart, Yale, Jean-Francois, Ekoe, Jean-Marie, Lin, Peter J., Goodman, Shaun G., Yan, Andrew T.
Format: Artikel
Sprache:eng
Schlagworte:
Antihypertensive Agents - therapeutic use
Antihypertensives
Blood Glucose
Blood pressure
Cardiovascular disease
Cardiovascular Diseases - complications
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - prevention & control
Cholesterol, LDL - blood
Coronary vessels
Data collection
Diabetes
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - epidemiology
Glucose
Glycated Hemoglobin A - analysis
Glycemic Control
Heart Disease Risk Factors
Hemoglobin
Humans
Hypertension
Lipids
Mortality
Patients
Primary care
Risk factors
Statistical analysis
Time Factors
Type 2 diabetes mellitus
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Our objective was to examine risk factor modification targets and treatment in relation to duration of diabetes. The Diabetes Mellitus Status in Canada (DM-SCAN) study collected data on 5109 patients with type 2 diabetes mellitus (T2DM) in 2012 in primary care. We compared the prevalence of vascular complications, treatment targets, and interventions between patients with diagnosed diabetes duration ≤10 and > 10 years. Physicians more frequently assigned HbA1c (glycated hemoglobin) targets of 7.1–8.5% (54–69 mmol/mol) to patients with longer duration of diabetes (n = 1647) (19.8% vs 9.5%, p 
ISSN:1056-8727
1873-460X
DOI:10.1016/j.jdiacomp.2021.107997